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From the Society for Clinical Vascular Surgery
A rare case of Clostridium septicum aortitis with colon
adenocarcinoma
Niti Shahi, MD, Mariano Arosemena, MD, Jeontaik Kwon, MD, Paul DiMuzio, MD, Babak Abai, MD, and
Dawn M. Salvatore, MD, Philadelphia, Pa
ABSTRACT
Clostridium septicum aortitis is a rare, highly morbid condition typically accompanied by malignant disease, such as
hematologic cancer or colon adenocarcinoma. Presenting symptoms commonly described include acute onset of
abdominal pain, nausea, and fevers. Prompt diagnosis of infectious aortitis is critical to prevent deadly complications,
such as sepsis and vascular catastrophe. The described management largely involves surgical resection of the infected
aorta, débridement, and arterial revascularization through extra-anatomic bypass or aortic graft placement. (J Vasc Surg
Cases and Innovative Techniques 2018;4:87-90.)
We present the ﬁrst reported case of Clostridium septi-
cum aortitis with associated colon adenocarcinoma
successfully treated with excision and aortoiliac recon-
struction using an arterial homograft in addition to a
literature review. The patient’s consent was obtained for
publication.
CASE REPORT
A 66-year-old man without prior medical care presented with
a 3-day history of sharp right lower quadrant abdominal pain, fe-
vers, chills, and bloody bowel movements. He had originally pre-
sented to an outside hospital, where computed tomography
(CT) of the abdomen and pelvis showed marked thickening of
the cecum and ascending colon wall and gas in the walls of
the infrarenal abdominal aorta and inferior mesenteric artery.
On examination, the patient was nontoxic and hemodynami-
cally stable with a temperature of 102.3℉; the abdomen was dis-
tended and tender in the right lower quadrant without
peritoneal signs and no pulsatile mass, and femoral and pedal
pulses were 2þ bilaterally. Laboratory studies were notable for
leukocytosis to 19.5 cells per microliter of blood. Preliminary
blood cultures were positive for gram-positive rods, and he
was started on intravenous cefepime, vancomycin, and metroni-
dazole (Flagyl). Additional workup included esophagogastro-
duodenoscopy (given gastrointestinal bleed), the ﬁndings of
which were normal (speciﬁcally no aortoenteric ﬁstula), and co-
lonoscopy demonstrated cecal and rectal masses.
CT angiography of the abdomen and pelvis, performed for sur-
gical planning, demonstrated circumferential wall thickening
and air within the wall of the infrarenal aorta and a ﬂuid collec-
tion from the aortic bifurcation to the common iliac arteries,
concerning for infected infrarenal aorta (Fig 1). The patient un-
derwent urgent transabdominal removal of the infected
aortobi-iliac segment and in-line reconstruction with an
aortobi-iliac homograft and left renal artery reimplantation
into the homograft (Fig 2). Given the urgency of the procedure
and availability of homograft at our institution, homograft was
selected as the conduit of choice over alternatives such as a neo-
aortoiliac system (NAIS) procedure. The left renal artery required
reimplantation because of proximal inﬂammation extending to
the oriﬁce of this vessel, with a total renal ischemic time of 70mi-
nutes and reimplantation time of 15 minutes. Concurrently,
open right hemicolectomy was performed with the bowel left
discontinuous because of the patient’s septic state, lack of
bowel preparation, and presence of cecal and rectal masses.
The retroperitoneum was approximated over the graft using
2-0 Vicryl in a standard running fashion, and the abdominal
wall was left open with an ABThera wound vacuum (Acelity,
San Antonio, Tex). As planned, 2 days later, the patient under-
went end-ileostomy creation and abdominal wall closure. Intra-
operative aortic cultures grew C. septicum, and antibiotics were
narrowed to ampicillin-sulbactam (Unasyn). The rectal mass was
to be addressed at a later time.
His postoperative course was marked by acute renal failure;
serum creatinine concentration peaked at 6.2 mg/dL with
glomerular ﬁltration rate of 9.0 mL/min/1.73 m2 on postoperative
day 6, without need for hemodialysis. At 1 week postoperatively,
serum creatinine concentration was 2.2 mg/dL; it was nearly
normalized to 1.5 mg/dL with a glomerular ﬁltration rate of
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47.0 mL/min/1.73 m2 by discharge. Postoperatively, he remained
afebrile, and the white blood cell count normalized. He was
released on postoperative day 28 to a rehabilitation facility in sta-
ble condition with no systemic symptoms and planned 6-week
course of Unasyn from time of resection of the infectious nidus.
DISCUSSION
A PubMed search using the key words “aortitis,”
“mycotic,” “aneurysm,” “clostridium,” “colon,” and “aorta”
was conducted in September 2015 to ﬁnd a composite
of cases for our analysis. The search yielded 55 studies
published between 1976 and 2015 that were narrowed
by the following exclusion criteria: absence of both aorti-
tis and colon adenocarcinoma, aortitis due to organisms
other than C. septicum, patient outcomes not addressed,
presenting with aortic rupture, and paper not available in
English.1-19
C. septicum aortitis has a poor prognosis with a 50% to
100% mortality rate.3,20 Early surgical intervention for pa-
tients with C. septicum aortitis is necessary to prevent
progression to sepsis. The hypothesized relationship be-
tween colon cancer and C. septicum aortitis stems
from the anaerobic environment fostered by the tumor
cells optimal for C. septicum spores, which can hemato-
genously spread from the tumor site to the aorta.11 All
deaths in our review occurred in patients treated medi-
cally. For patients treated with antibiotics alone, high sur-
gical risk due to advanced age, acute clinical decline,
comorbidities, and preference of the patient contributed
to the decision to forgo surgery.
The options for surgical management of C. septicum
aortitis include axillobifemoral bypass (with excision of
the aorta), excision of the infected aorta and insertion
of an aortic graft, and NAIS procedure. In most cases,
nonsurgical treatment resulted in high morbidity that
outweighed the risks of surgery.19 A combination of early
surgical intervention and long-term antibiotics has
proved to be more effective than medical therapy
alone.19 The average length of parenteral antibiotic treat-
ment was 6 to 8 weeks postoperatively, and only 5 of 22
(22.7%) patients were treated with lifelong antibiotics.
Because of the higher rates of homograft resistance to
bacteria compared with other conduits, our patient
was prescribed a 6-week regimen of antibiotics instead
of lifelong antibiotic suppression.21 Our plan for follow-
up after completion of the course of antibiotics included
close clinical follow-up and postoperative CT angiog-
raphy at 6 months.
In a series by Lau et al,22 following 6 weeks of intrave-
nous antibiotics after open repair of mycotic aortic aneu-
rysms, lifelong suppression with narrow-spectrum oral
antibiotics (typically trimethoprim-sulfamethoxazole,
cephalexin, doxycycline, or metronidazole) was pre-
scribed. With the combined presence of colon cancer,
the addition of anaerobe coverage is recommended.
The duration of antibiotic use for C. septicum aortitis
may depend on persistence of the patient’s infectious
symptoms, intraoperative ﬁndings and surgical cultures,
mode of antibiotic administration, and speciﬁc antibiotic
regimens.
In our case review, in those treated surgically for aortitis,
31.8% (7/22) received axillobifemoral bypass, and 31.8%
(7/22) received an aortic graft. For critically ill patients,
an axillobifemoral bypass can serve as a bridge until
the patient is medically stabilized. In comparison to sur-
gical excision of the infected aorta and aortic graft recon-
struction, axillobifemoral bypass requires a shorter
operative time, and it has less hemorrhage and shorter
aortic cross-clamp time with the excision of the infected
aorta.23 Although axillobifemoral bypasses confer certain
Fig 1. Preoperative computed tomography (CT) scan of
Clostridium septicum aortitis showing free air in inferior
mesenteric artery on coronal section.
Fig 2. In situ aortobi-iliac homograft after débridement
and excision of infected aorta.
88 Shahi et al Journal of Vascular Surgery Cases and Innovative Techniques
June 2018
advantages over in situ aortic graft placement, stump
rupture and graft occlusion are the major postoperative
complications.
Unlike synthetic grafts, homografts appear to be more
mechanically stable and more resistant to infections
because of their immunologically inert property with
cryopreservation.23,24 Given the lower rate of postopera-
tive infections, cryopreserved homografts have become
more commonly used in the treatment of aortic graft in-
fections, aortoenteric ﬁstulas, and mycotic aneurysms.23
In an operative ﬁeld with an existing infection, homo-
grafts are probably preferred to synthetic grafts. Howev-
er, the major impediments to the widespread use of
homografts are availability and high cost. Because
of the relatively short history of homograft use in
treatment of mycotic aneurysms, there are limited
data on the long-term outcomes and complications of
these grafts.
In centers with limited access to homografts, antibiotic-
soaked prosthetic grafts are an alternative option for
aortic repair, speciﬁcally rifampicin-soaked Dacron grafts.
Both in situ repair options, homografts and antibiotic-
soaked grafts, avoid the risk of stump blowout feared in
extra-anatomic bypasses. Although Dacron antibiotic-
soaked grafts are less expensive than homografts, they
may be less effective at treating methicillin-resistant
Staphylococcus aureus and certain strains of Staphylo-
coccus epidermidis.25
The NAIS procedure, ﬁrst described by Clagett et al26 in
1993 and constructed with femoropopliteal vein conduit,
is another emerging option for repair, especially in cases
of aortic infection. The advantages of the NAIS approach
include low rates of recurrent infections (<2%) and
decreased rates of aortic stump rupture that are associ-
ated with axillofemoral grafts.27 The NAIS procedure
may not be ideal in patients with a known virulent path-
ogen because of a higher risk for persistent graft infec-
tion and sepsis.28 Another drawback is the length of
time associated with NAIS reconstruction, on average
554 minutes.27
Overall, one of the most common complications of sur-
gery in our analysis was acute kidney injury, probably sec-
ondary to preoperative exposure to contrast material and
intraoperative suprarenal clamping. Higher rates of renal
injury would be expected in patients with suprarenal
aortic clamping; however, because of the small number
of patients in this study, we found equal rates (28.6%)
of renal injury in patients with aortic grafts (2/7) and axil-
lobifemoral bypass grafts (2/7).
CONCLUSIONS
Excision and repair with homograft should be consid-
ered for deﬁnitive repair of C. septicum aortitis. Although
the literature is limited on this treatment, given the rarity
of C. septicum aortitis, this surgical option may be a safe
alternative to the NAIS procedure and axillobifemoral
bypass, especially in an emergent setting.
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